JPRN-jRCT2080222121未知1 期
DS-7113b Phase I study -Evaluation of the safety, tolerability and pharmacokinetics of DS-7113b, and the effect of food on the pharmacokinetics of DS-7113b after a single dose of DS-7113b (immediate and extended release formulations) in healthy male Japanese subjects
DAIICHISANKYO Co.,Ltd.0 个研究点目标入组 30 人开始时间: 2013年6月19日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 45age old（—）
- 性别
- Male
入选标准
- •Male Japanese
- •-Between the age of 20 and 45
- •-Between the BMI of 18.5 and 25.0
排除标准
- •-Presence or history of severe adverse reaction or sensitivity to any drug.
- •-Presence or history of drug or alcohol abuse. etc.
研究者
相似试验
未知
1 期
Phase 1 Study of U3-1287Advanced solid tumors not curable with, or not eligible for standard treatment(s)JPRN-jRCT2080221225DAIICHISANKYO Co.,Ltd.18
尚未招募
1 期
DS-7830A PHASE 1 STUDY-A study to assess the safety,tolerability, and pharmacokinetics of single and multiple oral administration of DS-7830a in Japanese healthy adults, and to evaluate the effect of food (high-fat and low-fat meal) on the pharmacokinetics of orally administrated DS-7830a in Japanese healthy adultsmajor depressive disorderJPRN-jRCT2051230152Inoguchi Akihiro64
进行中（未招募）
1 期
[M22-984] A Study to Assess Adverse Events and Change in Disease State of Intravenously (IV) Infused ABBV-383 of Adult Participants With Relapsed or Refractory Multiple Myeloma in JapaMultiple MyelomaJPRN-jRCT2011210079Satomi Natsuko12
未知
1 期
Phase 1 Study of CS-7017JPRN-jRCT2080220936DAIICHISANKYO Co.,Ltd.12
已完成
不适用
A phase I study assessing the safety and performance of VB5-845D-800CW, an anti-Epcam fluorescent agent, for the intraoperative detection of gastrointestinal canceresophageal/gastric- or colorectal cancer10017990NL-OMON48830eids Universitair Medisch Centrum34